Breakthrough Hungarian COVID Patent in Development
Hungarian research into COVID could lead to a groundbreaking patent. The director of research, development, and innovation at the Hungarian National Blood Transfusion Service revealed that a newly produced molecule called “Factor H” has shown promise in preventing inflammatory processes related to the virus.
The research team was inspired by the concept of passive immunity, which suggests that individuals who have recovered from COVID-19 may have substances in their blood that offer protection against reinfection. Through their studies, the Hungarian researchers discovered the potential of “Factor H” in inhibiting the inflammatory response associated with severe cases of the disease.
“Factor H” is a part of the complement system, an ancient component of the immune system that can regulate inflammation. The researchers have developed modified versions of this molecule and are exploring its experimental use to mitigate the harmful effects of cytokine storms, an excessive immune response observed in severe COVID-19 cases.
The director emphasized that their discovery is unique and has the potential to be patented. The application of “Factor H” could include infusion therapy to combat inflammatory processes and remove harmful substances from the blood to improve patient outcomes.
In related news, concerns have arisen about the potential spread of the omicron variant virus, known as FLiRT, in Hungary. Virologists are advising individuals, especially those in high-risk categories, to remain cautious during crowded events and travel, including the upcoming UEFA Euro 2024 and the Olympics.
FLiRT presents with common respiratory symptoms such as fever, headache, and runny nose, but can lead to serious complications in vulnerable populations. Virologists are closely monitoring the situation and working on adapting vaccines to address emerging virus variants.
As the summer season approaches, it is crucial for individuals to take preventive measures to protect themselves and others from the spread of COVID-19 variants. Stay informed, follow recommended guidelines, and prioritize your health and safety during these challenging times.
